Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Ocular Therapeutix, Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 187 | 3 | 216 | +32 |
| Shares | 157.1M | 47.5K | 188.2M | +31.2M (+19.9%) |
| Value | $1.45B | $440.9K | $2.20B | +$746.8M (+51.4%) |
3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (50)
Institutions that held Ocular Therapeutix, Inc at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (18)
Institutions that held Ocular Therapeutix, Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Franklin Resources Inc | 1,170,163 | $10.9M |
| Pale Fire Capital SE | 530,135 | $4.92M |
| AXA S.A. | 516,500 | $4.79M |
| Renaissance Technologies LLC | 410,048 | $3.81M |
| Panagora Asset Management Inc | 296,546 | $2.75M |
| UBS Oconnor LLC | 210,205 | $1.95M |
| IMC-Chicago, LLC | 207,765 | $1.93M |
| Weiss Asset Management LP | 187,615 | $1.74M |
| Banco Santander, S.A. | 184,048 | $1.71M |
| Superstring Capital Management LP | 88,980 | $825.7K |
| Y-Intercept (Hong Kong) Ltd | 36,815 | $341.6K |
| Leonteq Securities AG | 25,000 | $232.0K |
| Group One Trading, L.P. | 11,950 | $110.9K |
| Quantessence Capital LLC | 11,467 | $106.4K |
| Ameritas Advisory Services, LLC | 291 | $2.70K |
| SRS Capital Advisors, Inc. | 87 | $808 |
| Twin Peaks Wealth Advisors, LLC | 2 | $25 |
| Federated Hermes, Inc. | 2 | $19 |
Not filed for Q3 2025 yet (3)
Institutions that held Ocular Therapeutix, Inc at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Graypoint LLC | 25,194 | $233.8K |
| CIBC World Markets Corp | 17,321 | $160.7K |
| Atlas Capital Advisors LLC | 5,000 | $46.4K |